Neuromuscular Monitoring in Children (6 Months - 2 Years) With Electromyography and Acceleromyography

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age6-2
SponsorMatias Vested

About this trial

The aim of this study is to compare AMG and EMG (Philips IntelliVue NMT module and Senzime TetraGraph) in the objective monitoring of neuromuscular blocking in children between the age of 6 months and 2 years.The monitoring will be done bilaterally either on n.ulnaris or n. tibialis. The hypothesis of the study is that AMG will indicate faster recovery time (time to return to TOF 90%) from neuromuscular block than EMG.

Eligibility criteria

Qualifiers

Patients 6 months - 2 years of age

Scheduled for elective surgery under general anaesthesia with intubation and use of rocuronium

American Society of Anesthesiologists (ASA) physical status classification I to III

Disqualifiers

Known allergy to rocuronium

Neuromuscular disease that may interfere with neuromuscular data

Indication for rapid sequence induction

Prone position

Trial design

Treatments tested in this trial

  • Acceleromyography (AMG)
  • Electromyography (EMG)

Treatment groups

120 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Matias Vested

Lead sponsor

Rigshospitalet, Denmark

Sponsor institution